Although higher expression of MALAT1 is associated with poorer outcomes in a number of cancers, Sun et al. (2009) have shown that MALAT1 is decreased in proliferating mammary glands of c-myc transgenic mice and further decreased to undetectable levels in mammary tumors. Here, MALAT1 is linked to breast cancer.